GleamWall
中文EN

AAWH Ascend Wellness Holdings, Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1756390 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-10.9%
TTM net income YoY-39.1%
TTM EPS YoY-45.0%
Revenue 3-yr CAGR7.2%
Net income 3-yr CAGR—

Margins

Gross margin33.9%
Operating margin-3.4%
Net margin-23.6%
FCF margin2.4%
EBITDA margin8.2%

Returns

ROE-1,004.3%
ROA-13.1%
ROIC (approx.)-6.1%
Asset turnover0.55x

Leverage & solvency

Liabilities / assets105.1%
Debt / equity—
Current ratio1.92x
Interest coverage-0.33x

Cash quality & payout

Operating cash flow / net income-0.32x
Accruals ratio-17.3%
Payout ratio—
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q3*2026-09-302026Q2*2026-06-302026Q1*2026-03-312025Q4*2025-12-312025Q3*2025-09-302025Q2*2025-06-302025Q1*2025-03-312024Q4*2024-12-31
Income statement
Revenue$130.02M$126.12M$116.93M$120.55M$124.73M$127.30M$128.00M$136.01M
Cost of revenue$76.93M$80.63M$72.05M$75.42M$81.13M$85.91M$88.44M$89.14M
Gross profit$53.09M$45.49M$44.88M$45.13M$43.60M$41.39M$39.56M$46.87M
SG&A expense$48.59M$40.21M$42.34M$45.30M$44.93M$42.39M$37.08M$40.77M
Operating income$4.50M$5.28M$2.55M-$17.17M-$1.32M-$1.00M$2.49M$6.10M
Interest expense$21.98M$20.80M$20.25M$15.48M$12.56M$12.06M$11.19M$11.71M
Pretax income-$17.42M-$15.53M-$17.59M-$32.47M-$13.55M-$12.58M-$8.23M-$6.00M
Income tax$10.53M-$5.72M$11.91M$16.24M$12.28M$11.83M$11.03M$10.79M
Net income-$27.95M-$9.81M-$29.49M-$48.70M-$25.82M-$24.41M-$19.26M-$16.79M
EBITDA$15.47M$15.81M$20.83M$3.36M$8.52M$8.25M$20.89M$23.57M
EPS (basic)-0.14-0.05-0.15—-0.13-0.12-0.09—
EPS (diluted)-0.14-0.05-0.15—-0.13-0.12-0.09—
Weighted avg. shares (diluted)203.23M203.01M202.45M—202.97M203.87M205.00M—
Balance sheet
Cash & equivalents$63.62M$67.00M$60.92M$85.68M$87.27M$95.27M$100.03M$88.25M
Receivables$24.64M$26.26M$26.42M$27.02M$28.85M$30.64M$36.72M$36.54M
Inventory$82.79M$82.27M$87.15M$84.71M$82.68M$82.32M$85.59M$89.55M
Current assets$181.19M$186.87M$188.96M$208.95M$209.21M$225.65M$237.38M$229.38M
PP&E, net$376.01M$381.56M$376.60M$382.40M$288.90M$277.90M$261.78M$260.46M
Goodwill$71.13M$65.37M$58.35M$58.45M$57.78M$54.00M$51.23M$49.60M
Intangibles$191.46M$195.96M$189.50M$196.07M$206.87M$206.70M$210.99M$205.50M
Total assets$879.80M$888.32M$872.09M$907.93M$900.36M$903.87M$916.73M$900.43M
Current liabilities$116.31M$112.64M$88.46M$109.01M$96.00M$100.79M$147.92M$144.54M
Short-term debt$29.34M$25.31M$9.78M$10.37M$25.30M$26.14M$81.41M$72.69M
Long-term debt$294.72M$293.52M$292.31M$291.10M$343.75M$323.44M$251.61M$214.42M
Total debt$324.06M$318.82M$302.09M$301.47M$369.05M$349.58M$333.02M$287.11M
Total liabilities$992.21M$973.41M$947.86M$954.55M$897.78M$875.71M$864.03M$828.63M
Shareholders' equity-$113.23M-$85.91M-$76.59M-$47.44M$1.75M$27.33M$51.88M$70.98M
Net debt$260.43M$251.82M$241.17M$215.80M$281.78M$254.31M$232.98M$198.86M
Shares outstanding——202.82M202.22M202.61M203.31M205.23M205.03M
Cash flow statement
Operating cash flow$5.43M$22.45M-$19.41M$16.32M-$2.00M$17.80M$5.94M$35.17M
Capital expenditure$4.79M$5.78M$5.18M$6.89M$6.45M$6.24M$6.42M$5.02M
Free cash flow$638,000$16.67M-$24.59M$9.42M-$8.45M$11.56M-$484,000$30.14M
Investing cash flow-$8.56M-$13.09M-$4.75M-$16.76M-$12.54M-$8.59M-$7.85M-$7.19M
Financing cash flow-$243,000-$3.28M-$592,000-$1.15M$6.54M-$13.98M$13.69M-$5.00M
Depreciation & amortization$10.97M$10.53M$18.28M$20.53M$9.84M$9.25M$18.40M$17.47M
Stock-based compensation$648,000$499,000$450,000$501,000$806,000$511,000$628,000$2.81M
Share buybacks$0$0$0—$586,000$649,000$345,000—

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.